The primary objective of this study is to estimate the distributions of HCV viral/human genotypes (including IL28B and inosine triphosphatase, ITPA), and HCV RNA level among ITPA gene among 1000 Han ethnic Chinese patients with HCV who are antiviral treatment naive at the time the study is conducted.
A sample of 1000 Han ethnic Chinese male or female who are ≥ 18 years old with a recent confirmation of anti-HCV-antibody positive and HCV RNA positive but antiviral treatment naive from 28 university affiliated hospital in China. The primary objective of this study is to estimate the distributions of HCV Viral genotyping(ie, genotype 1 through 6 and their known subtypes), and host genotypes, both inosine triphosphatase (ITPA) gene, and IL28B. This study also collects other data including patients' demographic and clinical characteristics. There is no active antiviral treatments and no follow-up in this study.
Study Type
OBSERVATIONAL
Enrollment
997
Lai Wei
Beijing, Beijing Municipality, China
Hepatitis C viral and host genotypes
To describe the distributions of both HCV viral and host genotypes (IL28B and ITPA) among antiviral treatment naive HCV patients
Time frame: Confirmation of an HCV infection 30 days prior to the recruitment
Hepatitis C RNA levels
To describe the distribution of HCV RNA levels in antiviral treatment-naive HCV patients
Time frame: Confirmation of an HCV infection 30 days prior to the recruitment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.